Immune effectors in colorectal cancer. A recent publication from ACREDIT describes how systemic release of osteoprotegerin during oxaliplatincontaining induction chemotherapy favors systemic outcome of sequential radiotherapy in rectal cancer. LINK
Anne Hansen Ree and Svein Dueland were both awarded important grants from the Norwegian Cancer Association (Kreftforeningen). Anne Hansen Ree’s project, “Shaping antitumor immunity in advanced colorectal cancer” will use a novel combination of...
Acredit member Sebastian Meltzer presents his research about how chemotherapy can kick-start the immune system at forskning.no LINK
